Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: 0.5% Bupivacaine and Dexamethasone: 25 ml of 0.5% bupivacaine with dexamethasone 8 mg between erector spinae muscle and T4 transverse process.
Control Intervention1: NIL: Ultrasonograph
Sponsors
Dr Aman Malawat
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with ASA Class I, II, III 2. Patients aged 25 to 65 years old 3. Patients scheduled for elective breast cancer surgery 4. Patientâ??s written and informed consent
Exclusion criteria
Exclusion criteria: 1. Patient with ASA Class IV & V 2. Patient refusal 3. Local infection at the site of injection 4. Allergy to study medications 5. Anatomic abnormalities 6. Systemic anticoagulation or coagulopathy 7. Inability to comprehend or participate in pain scoring system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total number of cases which were converted to general anaesthesiaTimepoint: 40 mins | — |
Secondary
| Measure | Time frame |
|---|---|
| Average duration to achieve surgical analgesia .Timepoint: 40 mins;Average duration to perform block .Timepoint: 30 mins ;Average time duration to give first postoperative analgesic (rescue analgesia) .Timepoint: 48 hours;Patient and surgeon compliance.Timepoint: 48 hours;Severity of postoperative pain via visual analogue pain scale at rest (VASR) and with movement (dynamic).Timepoint: 48 hours;Total cumulative dose of analgesic needed in first 48 hours after surgery.Timepoint: 48 hours | — |
Countries
India
Contacts
Public ContactDr Aman Malawat
Mahatma Gandhi Medical College and Hospital, Jaipur
Outcome results
None listed